Market Cap 115.36M
Revenue (ttm) 47.98M
Net Income (ttm) -68.57M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -142.91%
Debt to Equity Ratio 0.00
Volume 379,900
Avg Vol 505,504
Day's Range N/A - N/A
Shares Out 56.28M
Stochastic %K 85%
Beta 1.47
Analysts Sell
Price Target $5.00

Company Profile

Spero Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying and developing novel treatments for multi-drug resistant (MDR) bacterial infections and rare diseases in the United States. The company's product candidates include Tebipenem HBr (tebipenem pivoxil hydrobromide), an oral carbapenem-class antibiotic to treat complicated urinary tract infections, including pyelonephritis for adult patients, which is in Phase 3 development; and SPR720, a novel product candi...

Industry: Biotechnology
Sector: Healthcare
Phone: 857 242 1600
Address:
675 Massachusetts Avenue, 14th Floor, Cambridge, United States
GFstocktwits
GFstocktwits Oct. 5 at 4:03 AM
$SPRO Yep this certainly is a set and forget.... but after being in and out over the years, it is time to get a payout from this mob. Mkt cap of 115m is sooo low. Even if it went to the magical levels of 400m or 1bn or 2bn or.... when oh when......argh....
0 · Reply
MikiTrader
MikiTrader Oct. 4 at 4:20 AM
$SPRO They seem to have something they want to say, but they’re still hesitating. Maybe they haven’t been able to decide which direction to take.
1 · Reply
BillionerOfKing
BillionerOfKing Oct. 3 at 4:58 PM
$SPRO Current Stock Price: $2.03 Contracts to trade: $2.0 SPRO Oct 17 2025 Call Entry: $0.14 Exit: $0.19 ROI: 43% Hold ~23 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
DDel
DDel Oct. 2 at 7:44 PM
$SPRO buy low, hold long, sell high. patient investors
1 · Reply
n44
n44 Oct. 2 at 12:13 AM
$SPRO This board is worse than watching paint dry, Stocktwits should just eliminate this board, it’s quiet and silent. I post just to keep this board alive and hope for some interesting information, just a bunch of Michelle’s
1 · Reply
n44
n44 Oct. 1 at 7:49 PM
$SPRO The company has not yet announced that they will be attending the conference but I would say it’s very likely, since they are going to also release the phase 3 report as well as GSK finally filing the NDA.
0 · Reply
n44
n44 Oct. 1 at 2:25 PM
$SPRO Spero is presenting at the Infectious Disease Conference October 19 to the 21st. This should be the start of some catalysts for the stock, it’s worth a gamble on buying some shares at least for the short term, if nothing happens then it’s just another loss added to all the other losses.
0 · Reply
mdboss
mdboss Oct. 1 at 2:25 PM
$SPRO Could GSK be rising in anticipation of the Tebi launch in 2026???????
0 · Reply
highnihilism
highnihilism Oct. 1 at 12:37 PM
$ADUS Addus Homecare Trades: 3 | Total $: 340 | 0.02 × 90-Day Avg $: 18 K | Call $: 315 | Put $: 25 | Single-Leg: 100% | Multi-Leg: 0% | Contingent: – $RNGR Ranger Energy Services Trades: 5 | Total $: 314 | 0.37 × 90-Day Avg $: 852 | Call $: 314 | Put $: 0 | Single-Leg: 100% | Multi-Leg: 0% | Contingent: – $NEXA Nexa Resources Trades: 5 | Total $: 312 | 0.17 × 90-Day Avg $: 1.8 K | Call $: 312 | Put $: 0 | Single-Leg: 100% | Multi-Leg: 0% | Contingent: – $SPRO Spero Therapeutics Trades: 10 | Total $: 1.6 K | 0.06 × 90-Day Avg $: 26.3 K | Call $: 310 | Put $: 1.3 K | Single-Leg: 13% | Multi-Leg: 87% | Contingent: –
0 · Reply
Jabed206
Jabed206 Sep. 30 at 7:53 PM
$SPRO scyx...
1 · Reply
Latest News on SPRO
Spero Therapeutics, Inc. (SPRO) Q4 2024 Earnings Call Transcript

Mar 27, 2025, 8:31 PM EDT - 6 months ago

Spero Therapeutics, Inc. (SPRO) Q4 2024 Earnings Call Transcript


Spero Therapeutics to Present at Upcoming Investor Conference

Apr 26, 2023, 8:05 AM EDT - 2 years ago

Spero Therapeutics to Present at Upcoming Investor Conference


GFstocktwits
GFstocktwits Oct. 5 at 4:03 AM
$SPRO Yep this certainly is a set and forget.... but after being in and out over the years, it is time to get a payout from this mob. Mkt cap of 115m is sooo low. Even if it went to the magical levels of 400m or 1bn or 2bn or.... when oh when......argh....
0 · Reply
MikiTrader
MikiTrader Oct. 4 at 4:20 AM
$SPRO They seem to have something they want to say, but they’re still hesitating. Maybe they haven’t been able to decide which direction to take.
1 · Reply
BillionerOfKing
BillionerOfKing Oct. 3 at 4:58 PM
$SPRO Current Stock Price: $2.03 Contracts to trade: $2.0 SPRO Oct 17 2025 Call Entry: $0.14 Exit: $0.19 ROI: 43% Hold ~23 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
DDel
DDel Oct. 2 at 7:44 PM
$SPRO buy low, hold long, sell high. patient investors
1 · Reply
n44
n44 Oct. 2 at 12:13 AM
$SPRO This board is worse than watching paint dry, Stocktwits should just eliminate this board, it’s quiet and silent. I post just to keep this board alive and hope for some interesting information, just a bunch of Michelle’s
1 · Reply
n44
n44 Oct. 1 at 7:49 PM
$SPRO The company has not yet announced that they will be attending the conference but I would say it’s very likely, since they are going to also release the phase 3 report as well as GSK finally filing the NDA.
0 · Reply
n44
n44 Oct. 1 at 2:25 PM
$SPRO Spero is presenting at the Infectious Disease Conference October 19 to the 21st. This should be the start of some catalysts for the stock, it’s worth a gamble on buying some shares at least for the short term, if nothing happens then it’s just another loss added to all the other losses.
0 · Reply
mdboss
mdboss Oct. 1 at 2:25 PM
$SPRO Could GSK be rising in anticipation of the Tebi launch in 2026???????
0 · Reply
highnihilism
highnihilism Oct. 1 at 12:37 PM
$ADUS Addus Homecare Trades: 3 | Total $: 340 | 0.02 × 90-Day Avg $: 18 K | Call $: 315 | Put $: 25 | Single-Leg: 100% | Multi-Leg: 0% | Contingent: – $RNGR Ranger Energy Services Trades: 5 | Total $: 314 | 0.37 × 90-Day Avg $: 852 | Call $: 314 | Put $: 0 | Single-Leg: 100% | Multi-Leg: 0% | Contingent: – $NEXA Nexa Resources Trades: 5 | Total $: 312 | 0.17 × 90-Day Avg $: 1.8 K | Call $: 312 | Put $: 0 | Single-Leg: 100% | Multi-Leg: 0% | Contingent: – $SPRO Spero Therapeutics Trades: 10 | Total $: 1.6 K | 0.06 × 90-Day Avg $: 26.3 K | Call $: 310 | Put $: 1.3 K | Single-Leg: 13% | Multi-Leg: 87% | Contingent: –
0 · Reply
Jabed206
Jabed206 Sep. 30 at 7:53 PM
$SPRO scyx...
1 · Reply
Jabed206
Jabed206 Sep. 30 at 7:06 PM
$SPRO gsk has fingers in many pots, this one does not seem to be it immediate favourite
0 · Reply
JoeWo
JoeWo Sep. 30 at 4:44 AM
$SPRO So boring waiting for 2Q to finally be over and progress to finally begin.... Hoping for some really good news before 12/31.... All time high was $24+ per share. Would love to see that again some day.
0 · Reply
buyandsold
buyandsold Sep. 29 at 8:59 PM
$SPRO when may i have my $8 gsk?
1 · Reply
DDel
DDel Sep. 29 at 7:26 PM
$SPRO bought more, again.
0 · Reply
GFstocktwits
GFstocktwits Sep. 29 at 2:56 PM
$SPRO iterium is just for a uti, whereas spro is for a cuti which is cost saving re hospitalisation. Of coursed it would be good to back this up with a quick LDX-asx test for bacteria / vs / virus first.......
1 · Reply
aletz
aletz Sep. 29 at 2:18 PM
$SPRO You get to appreciate how fortunate you are here after seeing all those phase 2 and 3 failures today.
1 · Reply
GFstocktwits
GFstocktwits Sep. 29 at 1:07 PM
$SPRO not buying any more until a significant drop like 1.50 or less
1 · Reply
GFstocktwits
GFstocktwits Sep. 29 at 1:07 PM
$SPRO I would like this price to hold at this level of no less than the 1.89, otherwise if not...... I will grab some more , all the way down through to $1
0 · Reply
n44
n44 Sep. 29 at 6:34 AM
$SPRO The company GlaxoSmithKline will have a new CEO in January, I don’t know how this will work out for Spero. This is another question for to consider when buying shares of Spero, just don’t know.
1 · Reply
DDel
DDel Sep. 28 at 9:40 PM
$SPRO will add more again, tomorrow. gsk will get fda appr and buy it, all. long and very
1 · Reply
Goldwave9
Goldwave9 Sep. 28 at 1:35 PM
$SPRO With the right prompt,ChatGPT5 has given me continuing great selections. But I'm not sure I agree with this one. SPRO float is not low, and the beta is not especially high. Would anyone like to change my mind? (I never claimed to be a smart as ChatGPT5 lol)
2 · Reply
n44
n44 Sep. 26 at 2:39 PM
$SPRO The fact is no one on this message board wants to share their thoughts and opinions are meaningless because GSK holds all the power and the company SPERO never communicates to the shareholders, they are stuck waiting for their handout for the NDA. It’s very frustrating looking at this day after day, not for me anymore.
2 · Reply